Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 2:29 pm Sale | 2025-07-07 | 13G | QUINCE THERAPEUTICS, INC QNCX | Genextra S.p.A. | 0 0.000% | -14,033 (Position Closed) | Filing History |
| 2025-02-18 1:46 pm Purchase | 2024-10-18 | 13G | QUINCE THERAPEUTICS, INC QNCX | Genextra S.p.A. | 14,033 6.490% | 1,403 (+11.11%) | Filing History |
| 2023-12-14 5:51 pm Purchase | 2023-10-20 | 13G | QUINCE THERAPEUTICS, INC QNCX | Genextra S.p.A. | 12,630 5.890% | 12,630 (New Position) | Filing History |
| 2022-09-02 4:58 pm Sale | 2022-09-02 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Genextra S.p.A. | 4,000,000 13.400% | -31,994 (-0.79%) | Filing History |